Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
about
Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.PI3Kδ-selective and PI3Kα/δ-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma.MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma.Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival
P2860
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Silencing c-Myc translation as ...... in hematological malignancies
@ast
Silencing c-Myc translation as ...... in hematological malignancies
@en
type
label
Silencing c-Myc translation as ...... in hematological malignancies
@ast
Silencing c-Myc translation as ...... in hematological malignancies
@en
prefLabel
Silencing c-Myc translation as ...... in hematological malignancies
@ast
Silencing c-Myc translation as ...... in hematological malignancies
@en
P2093
P2860
P1433
P1476
Silencing c-Myc translation as ...... in hematological malignancies
@en
P2093
Barry Honig
Charles Karan
David A Fruman
Donald W Landry
Jeremie Vendome
Luigi Scotto
Mark R Lipstein
Michael A Mangone
Nicholas P Tatonetti
Owen A O'Connor
P2860
P356
10.1182/BLOOD-2016-08-731240
P407
P577
2017-01-05T00:00:00Z